Brief History (Timeline bar/chart)

  • 1995: Operations started with Isoniazid and Niacinamide APIs
  • 2002: Commissioning of new manufacturing facility
  • 2003: Started manufacturing Niacin for Jubilant Lifesciences under CRAMS model.
  • 2007: Aceclofenac and Sucralose APIs were added.
  • 2008: Commissioning of new production block.
  • 2010: Clopidogrel Bisulphate and Etodolac manufacturing started.
  • 2014: Several other APIs in Cardio and Neuro segment were developed.
  • 2018: WHO-GMP approval
  • 2019: Korean FDA approval and 2 CEP filings.
  • 2020: WC Approval for Clopidogrel
  • 2021: Commissioning of new state-of-the art 100KL Production Block and Pilot Plant for additional capacities.